Third and fourth operations for myocardial ischemia: short-term results and long-term survival

A W Pick1, C J Mullany, T A Orszulak

  • 1Section of Cardiac Surgery, Mayo Foundation, Mayo Clinic, Rochester, Minn 55905, USA.

Circulation
|December 31, 1997
PubMed

Insights

Repeated reoperative surgery for coronary artery disease can offer good long-term survival and improved clinical status for select patients. Despite increased mortality risks, this approach provides significant benefits for carefully chosen individuals needing further procedures.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery
  • Vascular Surgery

Background:

  • An increasing number of patients require repeat surgical interventions for myocardial ischemia.
  • The Mayo Clinic reports its experience with third and fourth reoperative surgeries for coronary artery disease.

Purpose of the Study:

  • To evaluate the outcomes of repeated reoperative surgery for coronary artery disease.
  • To assess survival rates and clinical status improvement in patients undergoing multiple cardiac procedures.

Main Methods:

  • A review of 67 consecutive patients undergoing third or fourth reoperative surgery for coronary artery disease between 1978 and 1992.
  • Analysis of clinical indications, surgical details, mortality, and long-term follow-up data.

Main Results:

  • The study included 67 patients (mean age at third procedure 63.4 years, at fourth 70.6 years).
  • Common indications included unstable angina (43%) and New York Heart Association class III angina (54%).
  • Graft failure was the primary cause of recurrent ischemia (96%); 11.9% in-hospital mortality and 75.6% 5-year survival were observed.

Conclusions:

  • Repeated reoperative surgery can lead to good long-term survival and improved clinical status in selected patients.
  • While mortality is increased, the benefits in carefully chosen individuals justify the procedure.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...